Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004991 |
---|---|
Receipt number | R000005934 |
Scientific Title | Phase II study of panitumumab with FOLFOX or FOLFIRI as 1st line treatment in patients with metastatic colorectal cancer in Japan |
Date of disclosure of the study information | 2011/02/26 |
Last modified on | 2017/02/05 11:06:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/02/01 12:30:43 | ||
2 | Update | 2011/05/06 09:20:46 | Recruitment status Last follow-up date |
|
3 | Update | 2012/02/01 16:40:56 | Last follow-up date |
|
4 | Update | 2012/08/01 20:45:32 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2013/08/01 10:32:00 | Recruitment status |
|
6 | Update | 2015/08/01 15:47:58 | Key exclusion criteria |
|
7 | Update | 2015/08/01 15:49:20 | Email |
|
8 | Update | 2017/02/05 11:06:36 | Recruitment status Date of closure to data entry Date trial data considered complete Publication of results Results |